Clinical Study of Eflornithine After Immunotherapy for High-risk Neuroblastoma（CSHEIN）

NCT07278674 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

High Risk Neuroblastoma

Interventions

DRUG: Oral administration of eflornithine for the prevention of high-risk neuroblastoma

Sponsor

Shanghai Children's Hospital

Collaborators

[object Object]